0219 Cefixime Supplement (English (GB)) MSDS - OXOID ...

Section 1. Chemical Product and Company Identification
Product No.
Trade name
Manufacturer
SR0191
Date of issue - 08/10/2008.
Cefixime Supplement
Oxoid Limited
Wade Road
Basingstoke
Hants RG24 8PW
ENGLAND
Tel: + 44 (0)1256 841144
Fax: + 44 (0)1256 463388
Supplier Oxoid Limited
Wade Road
Basingstoke
Hants RG24 8PW
ENGLAND
Tel: + 44 (0)1256 841144
Fax: + 44 (0)1256 463388
Section 2. Hazards Identification
Most Important Hazards
Human health hazards - Eyes
Human health hazards - Skin
Human health hazards - Ingestion
Not classified as hazardous.
Section 3. Composition, Information on Ingredients
CAS No.
Hazardous ingredients
Section 4. First Aid Measures
First Aid - Eyes
First Aid - Skin
May cause slight transient irritation.
SAFETY DATA SHEET
Cefixime Supplement
SR0191
Material may cause slight irritation on prolonged or repeated contact.
A large dose may have the following effects:- diarrhoea, nausea,
vomiting.
Mixture.
This preparation does not contain any substances presenting a health
hazard within the meaning of the Dangerous Substances Directive
67/548/EEC.
Wash out eye with plenty of water. Obtain medical attention if
soreness or redness persists.
Wash skin with soap and water.
First Aid - Ingestion
Wash out mouth with water. Have victim drink 1-3 glasses of water to
dilute stomach contents.
First Aid - Inhalation Remove from exposure. Seek medical attention if you feel unwell.
Section 5. Fire Fighting Measures
Extinguishing Media - Suitable
Protection of fire-fighters
Section 6. Accidental Release Measures
Use water spray, foam, dry chemical or carbon dioxide.
Be sure to use an approved/certified respirator or equivalent.
Personal Precautions Wear appropriate protective clothing.
Spill Sweep up into suitable containers for recovery or disposal.
CM Version - 3
Page: 1/3

Section 7. Handling and Storage
Handling
Storage
Section 8. Exposure Controls, Personal Protection
Protective Measures - Hands
Protective Measures - Body Lab coat.
Section 9. Physical and Chemical Properties
Physical state
Colour
Section 10. Stability and Reactivity
Stability
Section 11. Toxicological Information
Acute toxicity
Eye irritation
Skin irritation
Sensitization - Skin
Section 12. Ecological Information
Ecotoxicity
Section 13. Disposal Considerations
Date of issue - 08/10/2008.
Avoid contact with eyes, skin and clothing.
SAFETY DATA SHEET
Cefixime Supplement
Storage temperature should be controlled to between 2 and 8 °C.
Disposable vinyl gloves.
Pellets.
White.
Stable under normal conditions.
SR0191
Low order of acute toxicity.
Oral LD50 (rat) > 2000 mg/kg.
Dermal LD50 (rabbit) > 2000 mg/kg.
Inhalation LC50 (rat) > 20 mg/litre/4h.
The degree of irritation was insufficient to warrant labelling as an eye
irritant.
The degree of irritation was insufficient to warrant labelling as a skin
irritant.
The possibility of allergic sensitisation should be considered.
No relevant studies identified.
Disposal considerations
Dispose of in accordance with all applicable local and national
regulations.
Container information Containers should be cleaned by appropriate methods and then
re-used or disposed of by landfill or incineration as appropriate.
Section 14. Transport Information
UN :
UN number
Not classified.
ADR/RID : Class Not controlled under ADR (Europe).
Section 15. Regulatory Information
Risk Phrases
Safety Phrases
Not applicable.
Not applicable.
EC Classification This preparation is not classified as dangerous according to the EC
Directive 88/379/EEC.
CM Version - 3
Page: 2/3

Section 16. Other Information
MSDS first issued
MSDS data revised
Revisions Highlighted
02/05/2002
08/10/2008
Date of issue
Date of issue - 08/10/2008.
SAFETY DATA SHEET
Cefixime Supplement
SR0191
CM Version - 3 Page: 3/3